Understanding how O-GlcNAc transferase affects stem cell transitions
Elucidating the signaling and protein interaction networks of the O-GlcNAc transferase during embryonic stem cell state transitions
This study is looking at how a special enzyme helps control the changes that embryonic stem cells go through, which could lead to new treatments for patients by improving our understanding of how these cells work.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | La Jolla Institute for Immunology NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11086031 on NIH RePORTER |
What this research studies
This research investigates the role of O-GlcNAc transferase, a key enzyme that modifies proteins, in the transitions of embryonic stem cells. By examining how this enzyme interacts with other proteins and signaling pathways, the study aims to uncover the mechanisms that regulate cell differentiation and function. The approach involves advanced biochemical techniques to analyze protein modifications and their effects on cellular processes. Patients may benefit from insights gained into stem cell biology, which could inform future therapies.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with conditions related to stem cell abnormalities or those interested in advancements in regenerative therapies.
Not a fit: Patients with conditions unrelated to stem cell biology or those not seeking experimental treatments may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to breakthroughs in regenerative medicine and treatments for diseases related to stem cell dysfunction.
How similar studies have performed: While the specific focus on O-GlcNAc transferase is relatively novel, similar studies on protein modifications have shown promising results in understanding cellular processes.
Where this research is happening
La Jolla, United States
- La Jolla Institute for Immunology — La Jolla, United States (Active)
Researchers
- Principal investigator: Myers, Sam Anthony — La Jolla Institute for Immunology
- Study coordinator: Myers, Sam Anthony
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.